FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1513044495> ?p ?o ?g. }

• W1513044495 endingPage "10059" @default.
• W1513044495 startingPage "10045" @default.
• W1513044495 abstract "// Shaohua Li 1,* , Hui Li 1,* , Xiqin Yang 1,* , Wei Wang 1 , Aixue Huang 1 , Jie Li 1 , Xingliang Qin 1 , Fei Li 2 , Guanyi Lu 2 , Hongmei Ding 1 , Xueting Su 1 , Lvbin Hou 1 , Wei Xia 1 , Ming Shi 1 , Hongwen Zhang 3 , Qiang Zhao 1 , Jie Dong 1 , Xingfeng Ge 1 , Leqiao Sun 1 , Chenjun Bai 1 , Chaonan Wang 1 , Xuelian Shen 1 , Tao Fang 1 , Fusheng Wang 4 , Heqiu Zhang 1 and Ningsheng Shao 1 1 Beijing Institute of Basic Medical Sciences, Beijing, China 2 Beijing Institute of Pharmacology and Toxicology, Beijing, China 3 Department of Interventional Radiology, General Hospital of Fuzhou, Fuzhou, China 4 Center of Infectous Disease, Beijing 302 Hospital, Beijing, China * These authors contributed equally to this work Correspondence to: Ningsheng Shao, email: // Heqiu Zhang, email: // Keywords : vasorin, biomarker, hepatocarcinoma, subtractive-EMSA-SELEX, serum Received : December 23, 2014 Accepted : February 13, 2015 Published : March 12, 2015 Abstract We report a new biomarker of hepatocarcinoma, vasorin (VASN), screened by a subtractive EMSA-SELEX strategy from AFP negative serum of hepatocellular carcinoma (HCC) patients with extrahepatic metastases. VASN was verified to be highly expressed in sera of 100 cases of HCC patients compared with 97 cases of normal persons and 129 cases of hepatitis patients. Further validation by Q-PCR,IFA and Western blot showed higher expression of VASN at mRNA and protein levels in HCC cell lines and HCC tissues than in normal controls. RNA interference and forced overexpression assays verified that VASN promotes cell proliferation and migration and inhibits apoptosis. Down-regulation of microRNA miR145 and miR146a is an important mechanism leading to high expression of VASN. Conclusion: As a membrane protein and/or as free protein, VASN may be an effective target for biological treatment of liver cancer and is a potential biomarker for HCC diagnosis. Small molecular nucleotides targeting VASN are promising biological therapies to HCC." @default.
• W1513044495 created "2016-06-24" @default.
• W1513044495 creator A5001525815 @default.
• W1513044495 creator A5003060045 @default.
• W1513044495 creator A5005228021 @default.
• W1513044495 creator A5008763104 @default.
• W1513044495 creator A5010943367 @default.
• W1513044495 creator A5012395068 @default.
• W1513044495 creator A5014577744 @default.
• W1513044495 creator A5014829644 @default.
• W1513044495 creator A5030823667 @default.
• W1513044495 creator A5031263402 @default.
• W1513044495 creator A5033051190 @default.
• W1513044495 creator A5034507101 @default.
• W1513044495 creator A5035542490 @default.
• W1513044495 creator A5046597133 @default.
• W1513044495 creator A5051162009 @default.
• W1513044495 creator A5051520404 @default.
• W1513044495 creator A5055188575 @default.
• W1513044495 creator A5059199174 @default.
• W1513044495 creator A5065472770 @default.
• W1513044495 creator A5068252474 @default.
• W1513044495 creator A5070412038 @default.
• W1513044495 creator A5078521471 @default.
• W1513044495 creator A5079019775 @default.
• W1513044495 creator A5080760932 @default.
• W1513044495 creator A5081019724 @default.
• W1513044495 creator A5086873493 @default.
• W1513044495 date "2015-03-12" @default.
• W1513044495 modified "2023-10-18" @default.
• W1513044495 title "Vasorin is a potential serum biomarker and drug target of hepatocarcinoma screened by subtractive-EMSA-SELEX to clinic patient serum" @default.
• W1513044495 cites W1975487068 @default.
• W1513044495 cites W1986487051 @default.
• W1513044495 cites W1991182374 @default.
• W1513044495 cites W2001795292 @default.
• W1513044495 cites W2004554617 @default.
• W1513044495 cites W2007948538 @default.
• W1513044495 cites W2014238978 @default.
• W1513044495 cites W2014941346 @default.
• W1513044495 cites W2018567172 @default.
• W1513044495 cites W2019074803 @default.
• W1513044495 cites W2023921758 @default.
• W1513044495 cites W2027526894 @default.
• W1513044495 cites W2043137047 @default.
• W1513044495 cites W2047088479 @default.
• W1513044495 cites W2053821592 @default.
• W1513044495 cites W2055414401 @default.
• W1513044495 cites W2061916572 @default.
• W1513044495 cites W2075826965 @default.
• W1513044495 cites W2079321730 @default.
• W1513044495 cites W2081150390 @default.
• W1513044495 cites W2081271852 @default.
• W1513044495 cites W2104525153 @default.
• W1513044495 cites W2123922022 @default.
• W1513044495 cites W2133282256 @default.
• W1513044495 cites W2141387091 @default.
• W1513044495 cites W2152227601 @default.
• W1513044495 cites W2158583121 @default.
• W1513044495 cites W2314602855 @default.
• W1513044495 cites W2329367036 @default.
• W1513044495 cites W2418300279 @default.
• W1513044495 cites W2609912642 @default.
• W1513044495 doi "https://doi.org/10.18632/oncotarget.3541" @default.
• W1513044495 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4496339" @default.
• W1513044495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25826090" @default.
• W1513044495 hasPublicationYear "2015" @default.
• W1513044495 type Work @default.
• W1513044495 sameAs 1513044495 @default.
• W1513044495 citedByCount "30" @default.
• W1513044495 countsByYear W15130444952015 @default.
• W1513044495 countsByYear W15130444952016 @default.
• W1513044495 countsByYear W15130444952017 @default.
• W1513044495 countsByYear W15130444952018 @default.
• W1513044495 countsByYear W15130444952019 @default.
• W1513044495 countsByYear W15130444952020 @default.
• W1513044495 countsByYear W15130444952021 @default.
• W1513044495 countsByYear W15130444952022 @default.
• W1513044495 countsByYear W15130444952023 @default.
• W1513044495 crossrefType "journal-article" @default.
• W1513044495 hasAuthorship W1513044495A5001525815 @default.
• W1513044495 hasAuthorship W1513044495A5003060045 @default.
• W1513044495 hasAuthorship W1513044495A5005228021 @default.
• W1513044495 hasAuthorship W1513044495A5008763104 @default.
• W1513044495 hasAuthorship W1513044495A5010943367 @default.
• W1513044495 hasAuthorship W1513044495A5012395068 @default.
• W1513044495 hasAuthorship W1513044495A5014577744 @default.
• W1513044495 hasAuthorship W1513044495A5014829644 @default.
• W1513044495 hasAuthorship W1513044495A5030823667 @default.
• W1513044495 hasAuthorship W1513044495A5031263402 @default.
• W1513044495 hasAuthorship W1513044495A5033051190 @default.
• W1513044495 hasAuthorship W1513044495A5034507101 @default.
• W1513044495 hasAuthorship W1513044495A5035542490 @default.
• W1513044495 hasAuthorship W1513044495A5046597133 @default.
• W1513044495 hasAuthorship W1513044495A5051162009 @default.
• W1513044495 hasAuthorship W1513044495A5051520404 @default.
• W1513044495 hasAuthorship W1513044495A5055188575 @default.
• W1513044495 hasAuthorship W1513044495A5059199174 @default.
• W1513044495 hasAuthorship W1513044495A5065472770 @default.

• next